In fiscal year 2022, Dr. Reddy's Laboratories Limited generated the most revenue from its North American market valued at about 75 billion Indian rupees, indicating an increase over the previous year. The company's revenue from the emerging markets which included Russia, other Commonwealth of Independent States countries, Romania and Rest of the World markets was second in place with regard to revenue generation with about 46 billion Indian rupees.
Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Zoetis
Overview
4
- Premium Statistic Global animal health market 2002-2021
- Basic Statistic Distribution of global animal health care market by species 2021
- Premium Statistic Direct and indirect economic impact of animal health industry in the U.S. 2021
- Basic Statistic Economic performance per worker in the U.S. animal health industry 2021, by indicator
Revenue figures
4
Revenue distribution
4
Competitors
4
Other key data
5
Further related statistics
19
- Dr. Reddy's Laboratories' revenue FY 2014-2023
- Dr. Reddy's Laboratories' net worth FY 2014-2023
- Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Aurobindo Pharma's EBITDA margin FY 2013-2023
- Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Aurobindo Pharma's revenue share 2023, by market
- Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Aurobindo Pharma's EBITDA FY 2013-2023
- China's Kangmei Pharmaceuticals annual revenue 2016-2020
- Gland Parma's employee benefits expense FY 2021-2023
- Gland Parma's total value of assets FY 2019-2023
- Colombia: Market share of leading companies in 2016
Further Content: You might find this interesting as well
Statistics
- Dr. Reddy's Laboratories' revenue FY 2014-2023
- Dr. Reddy's Laboratories' net worth FY 2014-2023
- Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Aurobindo Pharma's EBITDA margin FY 2013-2023
- Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Aurobindo Pharma's revenue share 2023, by market
- Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Aurobindo Pharma's EBITDA FY 2013-2023
- China's Kangmei Pharmaceuticals annual revenue 2016-2020
- Gland Parma's employee benefits expense FY 2021-2023
- Gland Parma's total value of assets FY 2019-2023
- Colombia: Market share of leading companies in 2016
Dr. Reddy's Laboratories. (May 19, 2022). Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees) [Graph]. In Statista. Retrieved May 15, 2024, from https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/
Dr. Reddy's Laboratories. "Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees)." Chart. May 19, 2022. Statista. Accessed May 15, 2024. https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/
Dr. Reddy's Laboratories. (2022). Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees). Statista. Statista Inc.. Accessed: May 15, 2024. https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/
Dr. Reddy's Laboratories. "Revenue from Global Generic Drugs of Dr. Reddy's Laboratories Limited in Financial Year 2022, by Region (in Billion Indian Rupees)." Statista, Statista Inc., 19 May 2022, https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/
Dr. Reddy's Laboratories, Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees) Statista, https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/ (last visited May 15, 2024)
Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees) [Graph], Dr. Reddy's Laboratories, May 19, 2022. [Online]. Available: https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/